Package 76420-007-05

{"route": ["INTRA-ARTICULAR", "INTRALESIONAL", "INTRAMUSCULAR"], "spl_id": "ead06a22-6d5a-f9bb-e053-2a95a90aa12a", "openfda": {"unii": ["TI05AO53L7", "7BK02SCL3W"], "rxcui": ["578803"], "spl_set_id": ["c0a09d83-2405-450b-9f35-803d12823213"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "5 mL in 1 VIAL, MULTI-DOSE (76420-007-05)", "package_ndc": "76420-007-05", "marketing_start_date": "20200116"}], "brand_name": "Betamethasone Sodium Phosphate and Betamethasone Acetate", "product_id": "76420-007_ead06a22-6d5a-f9bb-e053-2a95a90aa12a", "dosage_form": "INJECTION, SUSPENSION", "pharm_class": ["Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]", "Corticosteroid [EPC]"], "product_ndc": "76420-007", "generic_name": "Betamethasone Sodium Phosphate and Betamethasone Acetate", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Betamethasone Sodium Phosphate and Betamethasone Acetate", "active_ingredients": [{"name": "BETAMETHASONE ACETATE", "strength": "3 mg/mL"}, {"name": "BETAMETHASONE SODIUM PHOSPHATE", "strength": "3 mg/mL"}], "application_number": "ANDA090747", "marketing_category": "ANDA", "marketing_start_date": "20100428", "listing_expiration_date": "20261231"}